Real-time enrollment status for this iga nephropathy clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 3:30 PM UTC
| NCT Number | NCT06712407 |
| Recruiting Status | Recruiting |
| Condition | IgA Nephropathy |
| Phase | PHASE4 |
| Target Enrollment | 60 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Calliditas Therapeutics AB |
| Last Updated on CT.gov | February 5, 2026 (Feb 5, 2026) |
As of July 18, 2026: Clinical trial NCT06712407 is currently recruiting participants. This phase4 study for iga nephropathy is actively seeking new participants at 37 locations across the United States. The study is sponsored by Calliditas Therapeutics AB. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06712407 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06712407 was last updated Feb 5, 2026 (February 5, 2026). HelloStudys verifies this status automatically.